Showing results (211-220 of 501) with videos related to
Sort By:
Pageof 51
Journal of Clinical Medicine|July 1, 2020
Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched SubtypesNeil K Jairath, Mark W Farha, Sudharsan Srinivasan, et al.International Journal of Radiation Oncology, Biology, Physics|May 21, 2020
A Signature That May Be Predictive of Early Versus Late Recurrence After Radiation Treatment for Breast Cancer That May Inform the Biology of Early, Aggressive RecurrencesCorey Speers, S Laura Chang, Andrea Pesch, et al.Nature Cancer|November 18, 2024
Transcription and DNA replication collisions lead to large tandem duplications and expose targetable therapeutic vulnerabilities in cancerYang Yang, Michelle L Badura, Patrick C O'Leary, et al.Cancer Discovery|December 9, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate CancerLisa N Chesner, Fanny Polesso, Julie N Graff, et al.Biorxiv : the Preprint Server for Biology|June 12, 2025
Genome-wide CRISPR screens identify PTGES3 as a novel AR modulatorHaolong Li, James E Melnyk, Becky Xu Hua Fu, et al.Nature Genetics|November 5, 2025
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancerHaolong Li, James E Melnyk, Becky Xu Hua Fu, et al.European Urology|December 18, 2018
Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.Brachytherapy|August 17, 2016
Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancerYu-Wei Chen, Vinayak Muralidhar, Brandon A Mahal, et al.Molecular Oncology|November 18, 2021
Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivityYing Z Mazzu, YuRou Liao, Subhiksha Nandakumar, et al.Nature Communications|November 14, 2022
Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistanceDhivya Sridaran, Surbhi Chouhan, Kiran Mahajan, et al.Pageof 51